chartexchange

MGX
Metagenomi Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:51:14 PM EST
0.70USD-2.059%(-0.02)119,309
Pre-marketNov 13, 2026 9:00:30 AM EST
0.714USD0.000%(0.00)
After-hoursNov 13, 2026 4:00:30 PM EST
0.6917USD-1.087%(-0.0076)

MGX Financials

In Q3 FY 2026 (ended ), Metagenomi Therapeutics, Inc. Common Stock (MGX) reported revenue of $2.18M, net income of −$21.13M, operating cash flow of −$19.08M, and assets of $157.39M (filed ).

Loading financial flows…